Sign Up Today and Learn More About Vantis Vascular Stock
Invest in or calculate the value of your shares in Vantis Vascular or other pre-IPO companies through EquityZen's platform.
Vantis Vascular Stock (VAVA)
Vantis Vascular develops technology for vascular interventions targeting complex arteries.
About Vantis Vascular Stock
Founded
2018
Headquarters
San Jose, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Vantis Vascular Press Mentions
Stay in the know about the latest news on Vantis Vascular
System and method for efficient intravascular lithotripsy
patents • Apr 02, 2025
Method and apparatus for catheter-based extracorporeal membrane oxygenation ( …
patents • Apr 02, 2025
Vantis Vascular and Lovell Announce Agreement to Provide CrossFAST™ Advanced Delivery System to VA Hospitals Nationwide
einpresswire • Mar 11, 2025
Enhanced guide extension system for the efficient delivery of leads
patents • Feb 07, 2025
Method and apparatus for antegrade transcatheter valve repair or implantation
patents • Feb 07, 2025
Vantis Vascular Management
Leadership team at Vantis Vascular
President and Chief Executive Officer
Jason Turner
Board Member
Tim Fischell
Join now and verify your accreditation status to gain access to:
- Vantis Vascular Current Valuation
- Vantis Vascular Stock Price
- Vantis Vascular Management
- Available deals in Vantis Vascular and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Vantis Vascular Cap Table and Funding History by Share Class and Liquidity Preferences
- Vantis Vascular Revenue and Financials
- Vantis Vascular Highlights
- Vantis Vascular Business Model
- Vantis Vascular Risk Factors
- Vantis Vascular Research Report from SACRA Research
Trading Vantis Vascular Stock
How to invest in Vantis Vascular stock?
Accredited investors can buy pre-IPO stock in companies like Vantis Vascular through EquityZen funds. These investments are made available by existing Vantis Vascular shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Vantis Vascular stock?
Shareholders can sell their Vantis Vascular stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
